•Eligible commercial patients may pay as little as $0 for their treatment
•There is a maximum benefit limit of $20,000 for product cost share per calendar year and $1,500 for the administration cost share reimbursement to the patient
•Patients are not eligible for the offer if they are selfpaying or if the patient is enrolled in a state or federal healthcare program, including but not limited to Medicare or Medicaid, Medigap, VA, DOD, or TRICARE
•Patients residing in Massachusetts and patients receiving IZERVAY treatment in Massachusetts are potentially eligible for copay assistance for the cost of IZERVAY only, and are not eligible for copay assistance for the administration of IZERVAY
•Patient questions and requests to discontinue participation in the program can be directed to 1888 C5MYWAY (18882569929) 8 AM to 8 PM ET Monday Friday